257 related articles for article (PubMed ID: 18704713)
1. Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis.
Heikkilä K; Harris R; Lowe G; Rumley A; Yarnell J; Gallacher J; Ben-Shlomo Y; Ebrahim S; Lawlor DA
Cancer Causes Control; 2009 Feb; 20(1):15-26. PubMed ID: 18704713
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.
Pine SR; Mechanic LE; Enewold L; Chaturvedi AK; Katki HA; Zheng YL; Bowman ED; Engels EA; Caporaso NE; Harris CC
J Natl Cancer Inst; 2011 Jul; 103(14):1112-22. PubMed ID: 21685357
[TBL] [Abstract][Full Text] [Related]
3. Associations of circulating C-reactive protein and interleukin-6 with survival in women with and without cancer: findings from the British Women's Heart and Health Study.
Heikkilä K; Ebrahim S; Rumley A; Lowe G; Lawlor DA
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1155-9. PubMed ID: 17548678
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis.
Zhou B; Shu B; Yang J; Liu J; Xi T; Xing Y
Cancer Causes Control; 2014 Oct; 25(10):1397-405. PubMed ID: 25053407
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
Siemes C; Visser LE; Coebergh JW; Splinter TA; Witteman JC; Uitterlinden AG; Hofman A; Pols HA; Stricker BH
J Clin Oncol; 2006 Nov; 24(33):5216-22. PubMed ID: 17114654
[TBL] [Abstract][Full Text] [Related]
6. Chronic inflammation and risk of lung cancer in older adults in the health, aging and body composition cohort study.
Demb J; Wei EK; Izano M; Kritchevsky S; Swede H; Newman AB; Shlipak M; Akinyemiju T; Gregorich S; Braithwaite D
J Geriatr Oncol; 2019 Mar; 10(2):265-271. PubMed ID: 30078713
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein, interleukin 6 and lung cancer risk: a meta-analysis.
Zhou B; Liu J; Wang ZM; Xi T
PLoS One; 2012; 7(8):e43075. PubMed ID: 22912790
[TBL] [Abstract][Full Text] [Related]
8. Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies.
Guo YZ; Pan L; Du CJ; Ren DQ; Xie XM
Asian Pac J Cancer Prev; 2013; 14(1):243-8. PubMed ID: 23534731
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
Pradhan AD; Manson JE; Rossouw JE; Siscovick DS; Mouton CP; Rifai N; Wallace RB; Jackson RD; Pettinger MB; Ridker PM
JAMA; 2002 Aug; 288(8):980-7. PubMed ID: 12190368
[TBL] [Abstract][Full Text] [Related]
10. Serum total thiol levels and the risk of lung, colorectal, breast and prostate cancer: A prospective case-cohort study.
Gào X; Wilsgaard T; Jansen EHJM; Xuan Y; Anusruti A; Brenner H; Schöttker B
Int J Cancer; 2020 Mar; 146(5):1261-1267. PubMed ID: 31125113
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older.
Pierce BL; Biggs ML; DeCambre M; Reiner AP; Li C; Fitzpatrick A; Carlson CS; Stanford JL; Austin MA
Cancer Causes Control; 2009 Sep; 20(7):1193-203. PubMed ID: 19267250
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer.
Poole EM; Lee IM; Ridker PM; Buring JE; Hankinson SE; Tworoger SS
Am J Epidemiol; 2013 Oct; 178(8):1256-64. PubMed ID: 23966559
[TBL] [Abstract][Full Text] [Related]
13. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
[TBL] [Abstract][Full Text] [Related]
14. Prevalent diabetes and risk of total, colorectal, prostate and breast cancers in an ageing population: meta-analysis of individual participant data from cohorts of the CHANCES consortium.
Amadou A; Freisling H; Jenab M; Tsilidis KK; Trichopoulou A; Boffetta P; Van Guelpen B; Mokoroa O; Wilsgaard T; Kee F; Schöttker B; Ordóñez-Mena JM; Männistö S; Söderberg S; Vermeulen RCH; Quirós JR; Liao LM; Sinha R; Kuulasmaa K; Brenner H; Romieu I
Br J Cancer; 2021 May; 124(11):1882-1890. PubMed ID: 33772152
[TBL] [Abstract][Full Text] [Related]
15. Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study.
Izano M; Wei EK; Tai C; Swede H; Gregorich S; Harris TB; Klepin H; Satterfield S; Murphy R; Newman AB; Rubin SM; Braithwaite D;
Int J Cancer; 2016 Mar; 138(5):1118-28. PubMed ID: 26413860
[TBL] [Abstract][Full Text] [Related]
16. Circulating C-Reactive Protein and Breast Cancer Risk-Systematic Literature Review and Meta-analysis of Prospective Cohort Studies.
Chan DS; Bandera EV; Greenwood DC; Norat T
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1439-49. PubMed ID: 26224798
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort.
Il'yasova D; Colbert LH; Harris TB; Newman AB; Bauer DC; Satterfield S; Kritchevsky SB
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2413-8. PubMed ID: 16214925
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.
Pradhan AD; Manson JE; Rifai N; Buring JE; Ridker PM
JAMA; 2001 Jul; 286(3):327-34. PubMed ID: 11466099
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts.
Bao Y; Giovannucci EL; Kraft P; Qian ZR; Wu C; Ogino S; Gaziano JM; Stampfer MJ; Ma J; Buring JE; Sesso HD; Lee IM; Rifai N; Pollak MN; Jiao L; Lessin L; Cochrane BB; Manson JE; Fuchs CS; Wolpin BM
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):855-61. PubMed ID: 23462920
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory Markers of CRP, IL6, TNFα, and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies.
Zeng F; Wei H; Yeoh E; Zhang Z; Ren ZF; Colditz GA; Tworoger SS; Su X
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1231-9. PubMed ID: 27277846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
